Document Detail

Pharmacological female contraception: an overview of past and future use.
MedLine Citation:
PMID:  15882120     Owner:  NLM     Status:  MEDLINE    
Female hormonal contraceptive methods have undergone slow change over the past four decades. Due to social, political and legal reasons, as well as medical complications, several new methods have been removed from the contraceptive armamentarium almost as quickly as they have been added. With worldwide unintended pregnancy rates approaching 50% of all pregnancies, there is an increased need for the development of new methods of effective, safe, acceptable hormonal contraception. Pharmacological methods of contraception are reversible and contraceptive steroids are now formulated in pills, patches, intravaginal rings, subdermal implants and injections. All currently marketed formulations are made from synthetic steroids and contain no natural oestrogens or progestins. This article reviews the current state of female contraception and explores future directions.
Megan A Economidis; Daniel R Mishell
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Expert opinion on investigational drugs     Volume:  14     ISSN:  1744-7658     ISO Abbreviation:  Expert Opin Investig Drugs     Publication Date:  2005 Apr 
Date Detail:
Created Date:  2005-05-10     Completed Date:  2006-11-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9434197     Medline TA:  Expert Opin Investig Drugs     Country:  England    
Other Details:
Languages:  eng     Pagination:  449-56     Citation Subset:  IM    
Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Women's and Children's Hospital, Los Angeles, CA 90033, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Cutaneous
Chemistry, Pharmaceutical
Contraception / methods
Contraceptives, Oral, Hormonal / administration & dosage*
Drug Delivery Systems*
Drug Implants
Injections, Subcutaneous
Intrauterine Devices
Reg. No./Substance:
0/Contraceptives, Oral, Hormonal; 0/Drug Implants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Physiology of thermoregulatory dysfunction and current approaches to the treatment of vasomotor symp...
Next Document:  Recent progress in the discovery and development of cyclin-dependent kinase inhibitors.